Sep 19 2009
Halocarbon Products Corporation, a leading worldwide producer of specialty fluorochemicals, has entered into a licensing agreement with IBM to access IBM's industry-leading portfolio of patents related to hexafluoroisopropanol-based photoresists for semiconductor manufacturing.
"Halocarbon has long produced hexafluoroisopropanol (HFIP) as a key component in the manufacture of the anesthetic sevoflurane," said Halocarbon CEO Peter Murin. "With this agreement, we can partner our fluorochemicals development and manufacturing expertise with IBM's leadership in developing advanced electronic materials such as photoresists."
"This agreement will allow us to leverage our HFIP business and provide reliable, regular, cost-effective, US-based production of advanced photoresist compounds," added Murin.
With headquarters in River Edge, New Jersey, and a state-of-the-art manufacturing plant in North Augusta, South Carolina, USA, Halocarbon is one of the world's leading producers of specialty fluorochemicals. Halocarbon products include inert lubricants, aliphatic fluorochemicals for pharmaceutical and agricultural chemical manufacturing, inhalation anesthetics and other specialty products.